Inception of Mylin Biotech. Started operations in Bangalore, India.
First Product Launch
Nitrophage Forte™ launched, for the management of Uremic pruritis associated with CKD1. Nitrophage™ launched for the management of
MHE2. Bangalore office established.
FIRST SYNBIOTIC IN INDIA
Niftyy trial published in IJBCP (First ever clinical trial established the role of synbiotics in management of inflammatory markers)
AMINASE & ENZOBIOTICS CT5
Aminase™ pre-clinical studies completed Aminase™ clinical trial completed in southern command and published Launch of Aminase Enzobiotics pre-clinical studies completed
ENTRY IN CRITICAL CARE
Protinace-98™ launched Patent applied for Aminase™ Enzobiotics-EETOX clinical trail initiated in ESRD patients EETOX globally the largest study on PBUT's
PUBLICATIONS & PATENTS
Enzotein™ clinical trial published in International Journal of Nephrology & Therapeutics First Indian trial presented in American Society of Nephrology conference, Washington Patent filed for Enzotein and Enzobiotic
MYLIN 2021
Enzobiotic pre-clinical study published Enzobiotic clinical trial due for publication
GLOBAL MARKET PENETRATION
MYLIN 2021
Enzobiotic pre-clinical study published. Enzobiotic clinical trial due for publication.
PUBLICATIONS & PATENTS
Enzotein™ clinical trial published in International Journal of Nephrology & Therapeutics. First Indian trial presented in American Society of Nephrology conference, Washington. Patent filed for Enzotein and Enzobiotic.
ENTRY IN CRITICAL CARE
Protinace 98™ launched. Patent applied for Aminase™. Enzobiotics™ clinical trial initiated in 5 major centers in India.
AMINASE & ENZOBIOTICS Clinical Trial
Aminase™ pre-clinical studies completed Aminase™ clinical trial completed in southern command and published Launch of Aminase Enzobiotics pre-clinical studies completed
FIRST SYNBIOTIC IN INDIA
Niftyy trial published in IJBCP (First ever clinical trial established the role of synbiotics in management of inflammatory markers).
First Product Launch
Nitrophage Forte™ launched, for the management of Uremic pruritis associated with Chronic Kidney Disease. Nitrophage™ launched for the management of
Minimal Hepatic Encephalopathy. Bangalore office established.